Royal Society of Chemistry Releases 160 years of research
The Royal Society of Chemistry has announced that its full collection of research journals are now available.
This is BIG! 160 years of research was just released to the pharma world.
The Royal Society of Chemistry has announced that its full collection of research journals are now available to companies via its ‘text and data mining’ solution; opening the door for fantastic opportunities throughout the pharma industry.
Available in machine-readable format, 160 years of research covering the A-Z of chemical science is now at the fingertips of R&D departments worldwide allowing the opportunity to extract, pinpoint and apply insights gleaned from it’s huge archive which is being added to daily.
Richard Kidd, Head of Chemistry Data at the organization said “It’s near impossible for researchers to be sure they’ve read all the relevant material, let alone set it in context with their companies’ knowledge. An important but hidden piece of information, or new connection, could enable new leaps of progress to a programme”.
Available in XML, tables, and images, the data from the London-based organization which boasts over 50k members is sure to enhance the growth of chemical science knowledge and is the perfect example of how data, and data sharing, can power an industry to the next level.
Stay up-to-date with all the latest pharmaceutical news with QUINTA-ANALYTICA.
18 July 2023
Challenges of a large-scale study of breast cancer
Our bioanalytical experts and a high-profile client team up for the development of a new therapy for breast cancer.
29 June 2023
EU funding for Quinta-Analytica laboratory in Brno (CZ) was succesfully completed.
After two years, the project to finance new equipment for the Quinta-Analytica laboratory in Brno was successfully completed. The investment from European Regional Development Fund was used in this project.
22 June 2023
Quinta Analytica Partners with EvidentIQ to Enhance Efficiency of Phase 1 Studies
EvidentIQ partners with Quinta-Analytica to enhance Phase 1 study efficiency